IRIS
SCARPIGNATO, Carmelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.150
EU - Europa 4.738
AS - Asia 3.248
Continente sconosciuto - Info sul continente non disponibili 46
SA - Sud America 12
OC - Oceania 6
AF - Africa 4
Totale 15.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.012
CN - Cina 2.465
IE - Irlanda 1.482
SE - Svezia 920
FI - Finlandia 804
DE - Germania 730
TR - Turchia 660
IT - Italia 327
UA - Ucraina 308
CA - Canada 133
SG - Singapore 62
GB - Regno Unito 56
EU - Europa 46
IN - India 23
NL - Olanda 22
IR - Iran 19
BE - Belgio 18
RU - Federazione Russa 16
AT - Austria 13
FR - Francia 13
RO - Romania 12
BR - Brasile 7
AU - Australia 5
BD - Bangladesh 5
IL - Israele 4
BG - Bulgaria 3
CL - Cile 3
HU - Ungheria 3
JP - Giappone 3
KR - Corea 3
LU - Lussemburgo 3
MX - Messico 3
EG - Egitto 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
AR - Argentina 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ES - Italia 1
HK - Hong Kong 1
HR - Croazia 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
ZA - Sudafrica 1
Totale 15.204
Salva come PNG Salva come JPEG
Città #
Dublin 1.481
Chandler 1.347
Jacksonville 879
Izmir 615
Dearborn 604
Beijing 588
Nanjing 522
Ashburn 519
San Mateo 423
Princeton 391
Wilmington 240
Parma 174
Shenyang 170
Ann Arbor 154
Nanchang 152
Helsinki 138
Hebei 124
Toronto 118
Kunming 100
Shanghai 94
Hefei 89
Tianjin 89
Jiaxing 84
Jinan 84
Seattle 77
Grafing 73
Changsha 72
Norwalk 65
Los Angeles 62
Bremen 43
Kocaeli 42
Guangzhou 37
Houston 35
Des Moines 32
Düsseldorf 32
Woodbridge 31
Hangzhou 30
New York 25
Zhengzhou 24
Rockville 22
Boardman 21
Borås 20
Singapore 20
Fremont 17
Brussels 16
Ningbo 15
Pune 15
Fuzhou 14
Shaoxing 14
Chengdu 13
Vienna 13
Washington 13
Haikou 12
Wuhan 11
Taizhou 10
Cambridge 9
Lanzhou 9
Taiyuan 9
Wenzhou 9
Timisoara 8
Bologna 7
Changchun 7
Milan 7
Ardabil 6
Frankfurt am Main 6
Guarapuava 6
London 6
Quzhou 6
Xian 6
Andover 5
Bangshal 5
Fairfield 5
Mazara Del Vallo 5
Mestre 5
Montréal 5
Redwood City 5
Rome 5
Edinburgh 4
Huizen 4
Leawood 4
Ankara 3
Auburn Hills 3
Augusta 3
Bangalore 3
Baotou 3
Budapest 3
Chongqing 3
Dundee 3
Florence 3
Focsani 3
Fryazino 3
Harbin 3
Luxembourg 3
Melbourne 3
Mexico City 3
Monmouth Junction 3
Moscow 3
Old Bridge 3
Orange 3
Padova 3
Totale 10.318
Salva come PNG Salva come JPEG
Nome #
Antidiarroici ed Antispastici 80
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel 78
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle 76
Antacids and alginates in the treatment of gastroesophageal reflux disease: how do they work and how much are they clinically useful? 75
Alginate containing formulations: are they all the same? 75
EFFECTS OF SOME ANTIULCER DRUGS ON ACUTE EXPERIMENTAL PANCREATITIS IN THE RAT. 74
Myths and misconceptions about chronic constipation 73
Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation 71
Caustic injury of the upper gastrointestinal tract: A comprehensive review 71
Dysphagia and clinical outcome after laparoscopic Nissen or Rossetti fundoplication: sequential prospective study 69
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 67
Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trials 66
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 66
Distinct receptors mediate gastrin-releasing peptide and neuromedin beta-induced delay of gastric of liquids in rats. 66
A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation 65
[Effect of cimetidine on acute experimental pancreatitis in the rat]. 65
Dysphagia aortica: a neglected symptom of aortoesophageal fistula 65
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 65
Corrosive Esophageal Strictures in Children:. Outcomes after Timely or Delayed Dilatation. 63
Acid suppression in Barrett's esophagus: why and how? 63
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 63
Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. Clin Exptl Rheumatol 2005; 23: 809-818 63
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 63
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 63
Caustic ingestion in children: is endoscopy always indicated? A perspective from a Sierra Leone experience 62
Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996. 61
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 61
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 61
Prolactin response to TRH after intravenous cimetidine. 61
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY 61
Early esophageal transit study after laparoscopic fundoplication: how useful is it? 60
Does the Learning Phase influence the late outcome of patients with gastroesophageal reflux disease after laparoscopic fundoplication? 60
Features and management of esophageal corrosive lesions in children in Sierra Leone: lessons learned from 175 consecutive patients 60
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 60
Italian consensus conference for colonic diverticulosis and diverticular disease 60
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 59
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 59
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 59
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 58
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population 57
Myths and facts in the use of anti-inflammatory drugs 57
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 57
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 57
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 56
Effetti della stimolazione dei recettori H2(STH2) con impromidina in pazienti affetti da cardiomiopatia dilatativa primitiva (CMPD) 56
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 56
Poor effectiveness of PPIs in Non-Erosive Reflux Disease: the truth in the end! 56
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 56
New therapeutic approaches for management of sport-induced muscle strains 55
Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention 55
[Protective effect of ranitidine in acute experimental pancreatitis in the rat]. 55
What are the indications for pH measurement both conventional and combined with event markers, in evaluating the symptoms of GER? 55
Editorial: towards extended acid suppression--the search continues 55
Recovery of Gastric Function in Chronic Atrophic Gastritis By Using L-Cysteine: A 3 Years Study 55
Action of MDL 646, a new synthetic prostaglandin, on gastric acid secretion of some experimental animals. 54
Different effects of the H2-antagonists on gastric emptying in the rat. 54
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 54
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study 54
ADVANCES IN GI PHARMACOLOGY AND THERAPEUTICS 53
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori 53
Rifaximin in the management of colonic diverticular disease 53
Action of caerulein on gastric emptying of the conscious rat. 53
Modern diagnosis of gastroesophageal reflux disease (GERD). 53
A simple method for the measurement of human gastric emptying: standardization of operative parameters. 53
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 53
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 53
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 53
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 53
Can gangrenous cholecystitis be prevented?: a plea against a "wait and see" attitude. 52
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 52
Spasmolytic effect of octylonium bromide on gastrointestinal motility in vitro. 52
[Cerebral homovanillic acid and audiogenic stress in the rat: effect of Cannabis resin]. 52
Antacid protection of the gastric mucosa: an overview. 52
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study 52
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 52
Farmaci dell'Apparato Digerente 51
"RESCUE" THERAPIES FOR THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION 51
Functional endoscopy : the physiological and pathophysiological basis of reflux disease, diagnosis and therapy 51
Current trends in the management of achalasia. 51
Acid-lowering drugs in the treatment of gastroesophageal reflux disease: an overview. 51
P.04.11 A NEW APPROACH TO DETECTION OF NON-RESPONDER PATIENTS IN GERD BY NON-INVASIVE MARKERS 51
ASSESSMENT OF SYMPTOMS IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD) 51
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 51
Effect of TRH on pentagastrin-induced gastric acid secretion. 50
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 50
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 50
Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives. 50
OC.18.1 ARE ALL PATIENTS WITH HISTOLOGICAL DIAGNOSIS OF ATROPHIC GASTRITIS REALLY AT RISK OF DEVELOPING GASTRIC CANCER? ASSESSMENT OF GASTRIC ACID PRODUCTION BY CORRELATION BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I 50
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 50
Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat. 49
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 49
P.01.11: Gastrin 17 in Singling out Patients with Different Pattern of Gastroesophageal Reflux: A Pilot Study using PH-Impedance as Reference Standard 49
P.1.325: USEFULNESS OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROP H IC GASTRITIS 49
Non Invasive Diagnosis of Upper GI Diseases in a Primary Care Setting: A Study on 1,900 Patients 49
Corrosive esophageal injuries in children. A shortlived experience in Sierra Leone 48
By which mechanism is the gastric emptying rate accelerated after fundoplication? 48
Working Team Report: Towards a GI Safer Antiinflammatory Therapy. 48
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air. 48
Sa1976 GastroPanel and OLGA: Two Innovative Tools for the Detection of Atrophic Gastritis. A Prospective Study in Primary Care 48
Toward Better Acid Suppression-Why Do We Need It? 48
Totale 5.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019851 0 0 0 0 0 0 0 0 0 0 740 111
2019/20203.801 957 631 107 36 253 416 484 88 151 295 87 296
2020/20211.217 3 103 63 6 284 8 64 3 441 57 162 23
2021/20221.704 17 4 1 66 61 77 125 308 72 227 201 545
2022/20234.813 671 395 260 341 345 533 20 284 1.779 15 131 39
2023/20241.264 81 177 40 72 177 371 43 117 56 130 0 0
Totale 15.347